Topokine Therapeutics has initiated dosing in a Phase 2, randomised controlled clinical trial of XAF5 Gel for reduction of excess submental fat, commonly referred to as ‘double chin’. XAF5 Gel

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In